MedPath

成都景泽生物制药有限公司

Ownership
-
Established
2017-09-07
Employees
-
Market Cap
-
Website
http://www.jingzepharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Recombinant Human Follitropin for Injection

Product Name
泽盼喜
Approval Number
国药准字S20250018
Approval Date
Apr 30, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.